Healthcare -
Biotechnology - NASDAQ - US
$ 1.605
-2.73 %
$ 49.8 M
Market Cap
-0.81
P/E
IMRX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities IMRX - Immuneering Corporation
28.4 M
LAST VALUE
-55.60%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR